Fabian Halleck

An evaluation of sirolimus in renal transplantation.

New perspectives of immunosuppression.

Volume matters: CT-based renal cortex volume measurement in the evaluation of living kidney donors.

Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.

Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.

The need for minimization strategies: current problems of immunosuppression.

'Suspended in a paradox'-patient attitudes to wait-listing for kidney transplantation: systematic review and thematic synthesis of qualitative studies.

Cardiac and renal function in a large cohort of amateur marathon runners.

Midterm echocardiographic follow-up of cardiac function after living kidney donation.

Advances in pharmacotherapy to treat kidney transplant rejection.

Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.

'I feel stronger and younger all the time'-perspectives of elderly kidney transplant recipients: thematic synthesis of qualitative research.

Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?

Improved Left Ventricular Structure and Function After Successful Kidney Transplantation.

Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects.

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection.

Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide.

Transplanting HCV-Infected Kidneys into Uninfected Recipients.

Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.

Assessment of the Kidney Donor Profile Index in a European cohort.

Validation of the Living Kidney Donor Profile Index in a European cohort and comparison of long-term outcomes with US results.

Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.

Risks and benefits of everolimus.

Predictors of graft survival at diagnosis of antibody-mediated renal allograft rejection: a retrospective single-center cohort study.

Intensive monitoring of post filter ionized calcium concentrations during CVVHD with regional citrate anticoagulation: A retrospective study.

Mucosal associated invariant T cells are differentially impaired in tolerant and immunosuppressed liver transplant recipients.

SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.

Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles.

Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.

eHealth in transplantation.

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center.

Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.

The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single-center cohort study.

The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients - a cross-sectional prospective observational clinical study.

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients.

Coronavirus Disease 2019 Associated Risk Score, Behavior, and Symptom Prevalence in German Transplant Recipients.

A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.

What happens after graft loss? A large, long-term, single-center observation.

Tomoelastography for Longitudinal Monitoring of Viscoelasticity Changes in the Liver and in Renal Allografts after Direct-Acting Antiviral Treatment in 15 Kidney Transplant Recipients with Chronic HCV Infection.

STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in Germany.

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation.